US: FDA approves first vaccine to protect newborns from Respiratory Syncytial Virus
First Published: 22nd August, 2023 8:44 IST
The vaccine, made by Pfizer, is given to mothers late in their pregnancies and provides protection to infants through their first six months of life.
The US Food and Drug Administration (FDA) on Monday approved the first vaccine that protects newborns from Respiratory Syncytial Virus (RSV), CNN reported.
The vaccine, made by Pfizer, is given to mothers late in their pregnancies and provides protection to infants through their first six months of life.
In a trial of more than 7,000 pregnant people and their infants, the vaccine, named Abrysvo, cut the risk that infants needed to see a doctor or be admitted to the hospital.
RSV is a common illness and a major cause of hospitalization in infants and the elderly each year. It typically hits hardest during the winter months, and the last RSV season was longer and more severe than usual, overwhelming children’s hospitals.
Director of the FDA’s Center for Biologics Evaluation and Research, Peter Marks in a statement said: “RSV is a common cause of illness in children, and infants are among those at highest risk for severe disease, which can lead to hospitalization.”
“This approval provides an option for healthcare providers and pregnant individuals to protect infants from this potentially life-threatening disease,” he added as per CNN.
As per CNN, there are now several offerings to protect against RSV, including a recently approved antibody shot that can be given to all infants after birth and new vaccines for people 60 and older.
Pfizer’s senior vice president and chief scientific officer for vaccine research and development Annaliesa Anderson said in a statement: “ABRYSVO’s approval as the first and only maternal immunization to help protect newborns immediately at birth through six months from RSV marks a significant milestone for the scientific community and for public health.”
Pfizer has said that maternal vaccination could prevent up to 16,000 hospitalizations and more than 300,000 visits to the doctor due to RSV each year if the vaccine were universally applied. (ANI)
Also Read:
COMMENTS
TOPMOST STORY NOW
Live Meghalaya govt to relocate 200 vendors from Police Bazar, here is what they have to say
17th May 2024Live Rs 69 cr Sikkim State Bank fraud: FIR against GM, 2 others
17th May 2024Live Tripura is to be first NE state to implement CAA
17th May 2024Live Itanagar dog bite cases: Municipal Corporation appeals people not to kill stray dogs
17th May 2024WE RECOMMEND
Advisory for Indians travelling to Laos, Cambodia for jobs
The advisory outlines significant risks associated with fraudulent job offers and emphasizes the need for caution.
17th May 2024Kim Jong Un’s sister says N Korea’s weapons not for exports after US sanctions Russian firms
Kim Yo-jong's statement comes amid US claims that North Korea has supplied weapons to Russia to support the latter's war in Ukraine.
17th May 2024‘Let’s get ready to Rumble’: Trump, Biden set to debate in June, September
The first debate by CNN will be held on June 27, while the second debate will be held on September 10 by ABC News.
16th May 2024France declares state of emergency in New Caledonia as violent protests rage
The state of emergency came into effect at 8 pm (Paris time) on Wednesday and 5 am in Noumea, the island's capital.
16th May 2024US: Donald Trump’s former lawyer wants him convicted in ‘hush money’ case
Trump said, "'Don't worry. I'm the president of the United States,'" according to Cohen.
15th May 2024